Products

DYSPORT®

US FDA-approved, highly purified botulinum toxin type A effectively relaxes overcontracted muscles, smoothing wrinkles and fine lines. It offers natural-looking1 results that can last up to 5 months2, with a satisfaction rate of 98%1.

1. Schlessinger J et al. Dermatol Surg, 2021;47(4): 504-509
2. Kassir R et al. Dermatol Ther. 2013;3(2):179–189.

RESTYLANE®

The world’s first non-animal stabilized hyaluronic acid filler, featuring our exclusive patented NASHA® and OBTTM series1-3, allows you to tailor your contour to your individual needs.

1. Belmontesi M, De Angelis F, Di Gregorio C, et al. J Drugs Dermatol. 2018;17(1):83-88.
2. Reuther T, Bayrhammer J, Kerscher M. Arch Dermatol Res. 2010;302:37-45.
3. Streker M, Reuther T, Krueger N, et al. J Drugs Dermatol. 2013;12:990-994.

RESTYLANE® 
SKINBOOSTERS™

The only skin hydration solution that provides six key benefits1-8 and lasts up to 15 months9-10.

1. Dierickx C, et al. Dermatol Surg 2018;44 Suppl 1:S104–S18Gubanova E, et al. J Drugs Dermatol 2015;14(3):288–298.
2. Kerscher M, et al. Dermatol Surg 2008;34(5):720–726. 
3. Kim J. Arch Aesthetic Plast Surg 2014;20(2):97–103. 
4. Lee B, et al. Arch Plast Surg 2015;42(3):282–287. 
5. Ribé A, et al. J Cosmet Laser Ther 2011;13(4):154–161.
6. Williams S, et al. J Cosmet Dermatol 2009;8(3):216–225.
7. Wu Y, et al. J Cosmet Dermatol 2020;19(7):1627–1635.
8. Belmontesi M, De Angelis F, Di Gregorio C, et al. J Drugs Dermatol. 2018;17(1):83-88.
9. Wu Y, et al. J Cosmet Dermatol 2020;19(7):1627–1635

SCULPTRA®

The only US FDA-approved injectable poly-L-lactic acid (PLLA-SCA) product*, which stimulates a 67% increase in Type 1 collagen production within three months1, restores a youthful appearance, and provides results lasting up to 25 months2-3

* Summary of Safefy and Effectiveness data. Available at: https://www.accessdata.fda.gov/cdrh_docs/pdf3/p030050s002b.pdf  Accessed August 2021.

1. Goldberg D, et al. Dermatol Surg. 2013:39(6):915-922.
2. Narin RS, et al. J Am Acad Dermatol. 2010; 62(3):448-462.
3. Brandt FS, et al. Aesthet Surg J. 2011; 31(5):521-528.